Generation and Integrated Analysis of Advanced Patient‐Derived Orthoxenograft Models (PDOX) for the Rational Assessment of Targeted Therapies in Endometrial Cancer

Clinical management of endometrial cancer (EC) is handicapped by the limited availability of second line treatments and bona fide molecular biomarkers to predict recurrence. These limitations have hampered the treatment of these patients, whose survival rates have not improved over the last four dec...

Descripción completa

Detalles Bibliográficos
Autores principales: Devis‐Jauregui, Laura, Vidal, August, Plata‐Peña, Laura, Santacana, Maria, García‐Mulero, Sandra, Bonifaci, Nuria, Noguera‐Delgado, Eulàlia, Ruiz, Nuria, Gil, Marta, Dorca, Eduard, Llobet, Francisco J., Coll‐Iglesias, Laura, Gassner, Katja, Martinez‐Iniesta, Maria, Rodriguez‐Barrueco, Ruth, Barahona, Marc, Marti, Lola, Viñals, Francesc, Ponce, Jordi, Sanz‐Pamplona, Rebeca, Piulats, Josep M., Vivancos, Ana, Matias‐Guiu, Xavier, Villanueva, Alberto, Llobet‐Navas, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811454/
https://www.ncbi.nlm.nih.gov/pubmed/36373729
http://dx.doi.org/10.1002/advs.202204211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811454/
https://www.ncbi.nlm.nih.gov/pubmed/36373729
http://dx.doi.org/10.1002/advs.202204211

Ejemplares similares